Study of Humoral Immunity against Coronavirus Infection COVID-19 in Vaccinated Individuals with Vaccines Available in the Republic of Belarus (Sputnik V (Gam-COVID-Vac), RF and Sinopharm (BBIBP-CorV), PRC)
Relevance. Many countries around the world are developing effective vaccines against SARS-CoV-2. The measure of the effectiveness of the vaccination process has traditionally been antibody production. The frequency and intensity of adverse reactions is also an important factor in making a decision r...
Saved in:
Main Authors: | K. S. Korsak, I. O. Stoma, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2023-03-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/1742 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers
by: Alexis Hipólito García, et al.
Published: (2025-06-01) -
Immunogenicity evaluation of Gam-COVID-Vac (Sputnik V)
by: I. A. Kirillov, et al.
Published: (2022-12-01) -
Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data
by: A. N. KULIKOV, et al.
Published: (2022-11-01) -
The use of the combined vector vaccine GamCOVID-Vac (Sputnik V) in patients with immuno-inflammatory rheumatic diseases: safety issues-news
by: A. N. Kulikov, et al.
Published: (2023-06-01) -
Thrombosis in unvaccinated and Gam-COVID-Vac-vaccinated patients with COVID-19
by: A. G. Moiseeva, et al.
Published: (2022-08-01)